Former Chief Scientific Officer (5) · Bolt Biotherapeutics, Inc. (BOLT)

David Dornan

A named executive officer of Bolt Biotherapeutics in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$2,231,676

Salary $405,000Stock awards $0Bonus $162,000

FY2020: $576,781

2nd of 5 named executive officers at Bolt Biotherapeutics by FY2021 total.

5 named officers on file for Bolt Biotherapeutics, FY2021

David Dornan’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Bolt Biotherapeutics’s whole pay program stands against its peers

  • Bolt Biotherapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BOLT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2022 (DEF 14A).

Free

Get David Dornan’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

David Dornan compensation by year

Bolt Biotherapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Bolt Biotherapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$310,167$405,000
Bonus$109,620$162,000
Stock awards$0$0
Option awards$154,286$1,651,596
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$2,708$13,080
Total$576,781$2,231,676

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Bolt Biotherapeutics, Inc. DEF 14A filed April 28, 2022, accession 0000950170-22-006528, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Bolt Biotherapeutics, Inc. filed document, accession 0000950170-22-006528. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2022.

$577K
$2.2M
FY20
FY21
SalaryBonusOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option31,102—$2.73

Per the Outstanding Equity Awards at Fiscal Year-End table in Bolt Biotherapeutics, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Bolt Biotherapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Randall SchatzmanChief Executive Officer$5,935,603
David Dornan · this pageFormer Chief Scientific Officer (5)$2,231,676
Edith PerezChief Medical Officer$2,128,771
William QuinnChief Financial Officer$2,065,131
Grant YonehiroChief Business Officer$2,021,431

The full Bolt Biotherapeutics compensation record

free company brief

This page is one person within Bolt Biotherapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Bolt Biotherapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

David Dornan's compensation dossier · One-time report. No refunds.